121 related articles for article (PubMed ID: 16600583)
1. Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls.
Nilsson BM; Hultman CM; Wiesel FA
Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):339-46. PubMed ID: 16600583
[TBL] [Abstract][Full Text] [Related]
2. Test-retest stability of the oral niacin test and electrodermal activity in patients with schizophrenia.
Nilsson BM; Hultman CM; Ekselius L
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):367-72. PubMed ID: 19864122
[TBL] [Abstract][Full Text] [Related]
3. Niacin skin flush test: a research tool for studying schizophrenia.
Nadalin S; Buretić-Tomljanović A; Rubesa G; Tomljanović D; Gudelj L
Psychiatr Danub; 2010 Mar; 22(1):14-27. PubMed ID: 20305586
[TBL] [Abstract][Full Text] [Related]
4. Cognition and autonomic function in schizophrenia: inferior cognitive test performance in electrodermal and niacin skin flush non-responders.
Nilsson BM; Holm G; Hultman CM; Ekselius L
Eur Psychiatry; 2015 Jan; 30(1):8-13. PubMed ID: 25169443
[TBL] [Abstract][Full Text] [Related]
5. Niacin subsensitivity is associated with functional impairment in schizophrenia.
Messamore E
Schizophr Res; 2012 May; 137(1-3):180-4. PubMed ID: 22445461
[TBL] [Abstract][Full Text] [Related]
6. Chaos in schizophrenia associations, reality or metaphor?
Bob P; Susta M; Chladek J; Glaslova K; Palus M
Int J Psychophysiol; 2009 Sep; 73(3):179-85. PubMed ID: 19166884
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in PLA2G6 and PLA2G4C genes for calcium-independent phospholipase A2 do not contribute to attenuated niacin skin flush response in schizophrenia patients.
Nadalin S; Radović I; Buretić-Tomljanović A
Prostaglandins Leukot Essent Fatty Acids; 2015 Sep; 100():29-32. PubMed ID: 26160611
[TBL] [Abstract][Full Text] [Related]
8. Niacin sensitivity and the arachidonic acid pathway in schizophrenia.
Messamore E; Hoffman WF; Yao JK
Schizophr Res; 2010 Sep; 122(1-3):248-56. PubMed ID: 20417059
[TBL] [Abstract][Full Text] [Related]
9. An association between niacin skin flush response and plasma triglyceride levels in patients with schizophrenia.
Nadalin S; Jonovska S; Šendula Jengić V; Buretić-Tomljanović A
Prostaglandins Leukot Essent Fatty Acids; 2020 Apr; 155():102084. PubMed ID: 32126479
[TBL] [Abstract][Full Text] [Related]
10. Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms.
Dishy V; Liu F; Ebel DL; Atiee GJ; Royalty J; Reilley S; Paolini JF; Wagner JA; Lai E
J Clin Pharmacol; 2009 Apr; 49(4):416-22. PubMed ID: 19246721
[TBL] [Abstract][Full Text] [Related]
11. Investigation of niacin on parameters of metabolism in a physiologic dose: randomized, double-blind clinical trial with three different dosages.
Schweikart J; Reimann J; Schön C
Int J Food Sci Nutr; 2009; 60 Suppl 5():192-202. PubMed ID: 19521894
[TBL] [Abstract][Full Text] [Related]
12. The impact of PLA2G4A and PTGS2 gene polymorphisms, and red blood cell PUFAs deficit on niacin skin flush response in schizophrenia patients.
Nadalin S; Giacometti J; Jonovska S; Tomljanović D; Buretić-Tomljanović A
Prostaglandins Leukot Essent Fatty Acids; 2013 Feb; 88(2):185-90. PubMed ID: 23219238
[TBL] [Abstract][Full Text] [Related]
13. Electrodermal complexity during the Stroop colour word test.
Svetlak M; Bob P; Cernik M; Kukleta M
Auton Neurosci; 2010 Jan; 152(1-2):101-7. PubMed ID: 19914149
[TBL] [Abstract][Full Text] [Related]
14. Patients' experiences of niacin-induced flushing in clinical practice: a structured telephone interview.
Kamal-Bahl S; Watson DJ; Ambegaonkar BM
Clin Ther; 2009 Jan; 31(1):130-40. PubMed ID: 19243714
[TBL] [Abstract][Full Text] [Related]
15. A genome-wide quantitative linkage scan of niacin skin flush response in families with schizophrenia.
Lien YJ; Huang SS; Liu CM; Hwu HG; Faraone SV; Tsuang MT; Chen WJ
Schizophr Bull; 2013 Jan; 39(1):68-76. PubMed ID: 21653277
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
[TBL] [Abstract][Full Text] [Related]
17. Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis.
Berger GE; Smesny S; Schäfer MR; Milleit B; Langbein K; Hipler UC; Milleit C; Klier CM; Schlögelhofer M; Holub M; Holzer I; Berk M; McGorry PD; Sauer H; Amminger GP
PLoS One; 2016; 11(2):e0148429. PubMed ID: 26894921
[TBL] [Abstract][Full Text] [Related]
18. Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease.
Maccubbin D; Koren MJ; Davidson M; Gavish D; Pasternak RC; Macdonell G; Mallick M; Sisk CM; Paolini JF; Mitchel Y
Am J Cardiol; 2009 Jul; 104(1):74-81. PubMed ID: 19576324
[TBL] [Abstract][Full Text] [Related]
19. Role of prostaglandin D2 and the autonomic nervous system in niacin-induced flushing.
Parson HK; Harati H; Cooper D; Vinik AI
J Diabetes; 2013 Mar; 5(1):59-67. PubMed ID: 22727040
[TBL] [Abstract][Full Text] [Related]
20. Publication recommendations for electrodermal measurements.
Boucsein W; Fowles DC; Grimnes S; Ben-Shakhar G; roth WT; Dawson ME; Filion DL;
Psychophysiology; 2012 Aug; 49(8):1017-34. PubMed ID: 22680988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
